IMEXHS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.475 AUD | -5.00% |
|
-5.00% | -29.10% |
| Apr. 25 | IMEXHS Completes AU$250,000 Conditional Placement | MT |
| Mar. 22 | IMEXHS Renews Two Enterprise Software Contracts; Shares Up 3% | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company is in a robust financial situation considering its net cash and margin position.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.78 for the current period. Therefore, the company is undervalued.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -29.10% | 14.46M | - | ||
| +9.80% | 34.16B | C | ||
| +24.92% | 8.13B | C- | ||
| +36.69% | 4.44B | B- | ||
| -28.70% | 2.7B | C- | ||
| -20.62% | 1.37B | B | ||
| -28.50% | 1.27B | - | C+ | |
| -32.48% | 1.18B | - | ||
| +12.29% | 1B | C | ||
| -37.86% | 870M | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
- Stock Market
- Equities
- IME Stock
- Ratings ImExHS Limited